Case number 2020-1098
Ferring B.V. v. Allergan, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | FERRING B.V. v. ALLERGAN, INC. [OPINION] [precedential] (0) |
| Dec 17, 2020 | 42 | Mandate issued to the United States District Court for the Southern District of New York. Service as of this date by the Clerk of Court. [743386] [JAB] [Entered: 12/17/2020 09:05 AM] (2) |
| Nov 10, 2020 | 41 | JUDGMENT. VACATED AND REMANDED. Terminated on the merits after oral argument. COSTS: Each Side Bears Its Own Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [734711] [MJL] [Entered: 11/10/2020 10:26 AM] (2) |
| Nov 10, 2020 | 40 | OPINION filed for the court by O'Malley, Circuit Judge; Reyna, Circuit Judge and Chen, Circuit Judge. Precedential Opinion. [734709] [MJL] [Entered: 11/10/2020 10:25 AM] (29) |
| Sep 17, 2020 | 39 | MODIFIED ENTRY: CORRECTED APPENDIX FILED (SUPPLEMENTAL) for Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc., Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation, and Serenity Pharmaceuticals, LLC. Number of Pages: 5631. Service: 09/17/2020 by email. [722538]--[Edited 09/18/2020 by MJL - compliance review complete] [Mary Bourke] [Entered: 09/17/2020 03:24 PM] (5631) |
| Sep 16, 2020 | 38 | NOTICE OF NON-COMPLIANCE: The submission of Ferring B.V., Ferring International Center SA, et. al., Supplemental Joint Appendix [37], is not in compliance with the rules of this court (see attached). Compliant appendix due 09/23/2020. Service as of this date by the Clerk of Court. [722141] [MJL] [Entered: 09/16/2020 11:54 AM] (1) |
| Sep 14, 2020 | 37 | FILED from Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Appellees Serenity Pharmaceuticals, LLC, Serenity Pharmaceuticals Corporation and Reprise Biopharmaceutics, LLC. Title: SUPPLEMENTAL APPENDIX. Service: 09/14/2020 by email. [721393] [20-1098]. This appendix is non-compliant. See Doc. No. [38]. [Mary Bourke] [Entered: 09/14/2020 03:30 PM] (5631) |
| Sep 4, 2020 | 36 | ORDER filed. Within 10 days from the date of this order, the parties are directed to file a supplemental appendix consisting of all material in the underlying record not already provided in complete form in the joint appendix. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [719690] [MJL] [Entered: 09/04/2020 01:46 PM] (2) |
| Sep 3, 2020 | 35 | Submitted after ORAL ARGUMENT by Mary W. Bourke for Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. and Ms. Sarah Elizabeth Spires for Serenity Pharmaceuticals Corporation, Serenity Pharmaceuticals, LLC and Reprise Biopharmaceutics, LLC. Panel: Judge: O'Malley , Judge: Reyna , Judge: Chen.Oral Argument Audio available here. [719387] [JCP] [Entered: 09/03/2020 01:39 PM] (0) |
| Aug 26, 2020 | 34 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 08/26/2020 by email. [717794] [20-1098] [Mary Bourke] [Entered: 08/26/2020 04:13 PM] (57) |
| Aug 17, 2020 | 33 | Clerk's letter to Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Appellees Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation and Serenity Pharmaceuticals, LLC regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [715285] [JAB] [Entered: 08/17/2020 02:17 PM] (0) |
| Aug 17, 2020 | 32 | Response to notice of oral argument from the Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 08/17/2020 by email. [715063] [20-1098] [Mary Bourke] [Entered: 08/17/2020 09:14 AM] (1) |
| Aug 12, 2020 | 31 | Response to notice of oral argument from the Appellees Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation and Serenity Pharmaceuticals, LLC. Service: 08/12/2020 by email. [714523] [20-1098] [Sarah Spires] [Entered: 08/12/2020 05:32 PM] (2) |
| Jul 21, 2020 | 30 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2009H. Case scheduled September 3, 2020. Response to Notice of Oral Argument due: 08/17/2020. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [708942] [JAB] [Entered: 07/21/2020 01:39 PM] (1) |
| Jun 15, 2020 | 28 | 6 paper copies of the Appendix (Vol. I - II) [15] received from Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. [702393] [CJF] [Entered: 06/19/2020 10:15 AM] (0) |
| Jun 12, 2020 | 29 | 6 paper copies of the Reply Brief [14] received from Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. [703445] [CJF] [Entered: 06/24/2020 04:00 PM] (0) |
| May 29, 2020 | 27 | 6 paper copies of the Opening Brief [8] received from Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. [701045] [CJF] [Entered: 06/15/2020 11:06 AM] (0) |
| May 29, 2020 | 26 | 6 paper copies of the Corrected Opening Response Brief [13] received from Appellees Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation and Serenity Pharmaceuticals, LLC. [698149] [CJF] [Entered: 06/01/2020 11:03 AM] (0) |
| May 27, 2020 | 25 | Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before June 08, 2020. See Administrative Order No. 20-01 (Mar. 20, 2020). [697112] [MMA] [Entered: 05/27/2020 10:48 AM] (0) |
| May 8, 2020 | 24 | The following conflict dates submitted by Sarah Elizabeth Spires for Serenity Pharmaceuticals Corporation, Serenity Pharmaceuticals, LLC and Reprise Biopharmaceutics, LLC have been accepted by the court: 07/06/2020, 07/07/2020, 07/08/2020, 07/09/2020, 07/10/2020, 09/02/2020. [692988] [JAB] [Entered: 05/08/2020 07:54 AM] (0) |
| May 8, 2020 | 23 | The following conflict dates submitted by Mary W. Bourke for Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. have been accepted by the court: 07/06/2020, 07/07/2020, 07/08/2020, 07/09/2020, 07/10/2020. [692987] [JAB] [Entered: 05/08/2020 07:53 AM] (0) |
| May 7, 2020 | 22 | Notice from Appellees Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation and Serenity Pharmaceuticals, LLC regarding conflicts with oral argument. Service: 05/07/2020 by email. [692931] [20-1098] [Sarah Spires] [Entered: 05/07/2020 04:21 PM] (3) |
| May 7, 2020 | 21 | Notice from Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. regarding conflicts with oral argument. Service: 05/07/2020 by email. [692863] [20-1098] [Mary Bourke] [Entered: 05/07/2020 02:34 PM] (3) |
| Apr 30, 2020 | 20 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [691462] [MMA] [Entered: 04/30/2020 05:59 PM] (1) |
| Apr 27, 2020 | 19 | 6 CD-ROMs of the Corresponding Briefs and Joint Appendix received from Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. [691211] [CJF] [Entered: 04/30/2020 11:39 AM] (0) |
| Apr 24, 2020 | 18 | Notice of paper filing of the Corresponding Briefs on CD Rom for Attorney Mary W. Bourke for Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 04/24/2020 by email. [689808] [20-1098] [Mary Bourke] [Entered: 04/24/2020 12:57 PM] (3) |
| Apr 24, 2020 | 17 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 04/24/2020 by email. [689804] [20-1098] [Mary Bourke] [Entered: 04/24/2020 12:52 PM] (3) |
| Apr 24, 2020 | 16 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 04/24/2020 by email. [689802] [20-1098] [Mary Bourke] [Entered: 04/24/2020 12:50 PM] (3) |
| Apr 24, 2020 | 15 | MODIFIED ENTRY: APPENDIX FILED for Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. Number of Pages: 1213. Service: 04/24/2020 by email. [689799]--[Edited 04/30/2020 by MMA - Reason: compliance review complete] [Mary Bourke] [Entered: 04/24/2020 12:48 PM] (1213) |
| Apr 17, 2020 | 14 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. Number of Pages: 30. Service: 04/17/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [688059]--[Edited 04/23/2020 by MMA - Reason: compliance review complete] [Mary Bourke] [Entered: 04/17/2020 06:20 PM] (39) |
| Apr 2, 2020 | 13 | MODIFIED ENTRY: CORRECTED BRIEF FILED for Appellees Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation and Serenity Pharmaceuticals, LLC. Number of Pages: 66. Service: 04/02/2020 by email. [683780]--[Edited 04/07/2020 by MMA - Reason: compliance review complete] [Sarah Spires] [Entered: 04/02/2020 02:19 PM] (77) |
| Apr 2, 2020 | 12 | Notice of Correction to Doc No. [9] for Appellees Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation and Serenity Pharmaceuticals, LLC. Service: 04/02/2020 by email. [683779] [20-1098] [Sarah Spires] [Entered: 04/02/2020 02:18 PM] (4) |
| Mar 27, 2020 | 11 | ORDER filed. The revised official caption is reflected in the order. Appellants' reply brief is due 04/17/2020. Service as of this date by the Clerk of Court. [682318] [MMA] [Entered: 03/27/2020 11:56 AM] (2) |
| Mar 24, 2020 | 10 | Entry of appearance for Sarah E. Spires as of counsel for Appellees Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation and Serenity Pharmaceuticals, LLC. Service: 03/24/2020 by email. [681365] [20-1098] [Sarah Spires] [Entered: 03/24/2020 12:46 PM] (2) |
| Mar 23, 2020 | 9 | MODIFIED ENTRY: BRIEF FILED for Appellees Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation and Serenity Pharmaceuticals, LLC. Number of Pages: 66. Service: 03/23/2020 by email. [680992]--[Edited 03/24/2020 by MMA - Reason: compliance review complete] This brief has been corrected. See Doc. No. [13] [Sarah Spires] [Entered: 03/23/2020 02:08 PM] (77) |
| Feb 10, 2020 | 8 | MODIFIED ENTRY: BRIEF FILED for Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. Number of Pages: 51. Service: 02/10/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [670012]--[Edited 02/25/2020 by MMA - Reason: compliance review complete] [Mary Bourke] [Entered: 02/10/2020 10:39 PM] (197) |
| Jan 21, 2020 | 7 | Notice of intent to file corresponding briefs on CD-ROM for Appellees Serenity Pharmaceuticals Corporation and Reprise Biopharmaceutics, LLC. Service: 01/21/2020 by email. [664829] [20-1098] [Sarah Spires] [Entered: 01/21/2020 04:21 PM] (3) |
| Jan 21, 2020 | 6 | Notice of intent to file corresponding briefs on CD-ROM for Appellants Ferring International Center SA, Ferring B.V. and Ferring Pharmaceuticals Inc.. Service: 01/21/2020 by email. [664414] [20-1098] [Mary Bourke] [Entered: 01/21/2020 08:18 AM] (3) |
| Dec 12, 2019 | 5 | NOTE TO FILE: FOR PRIOR ENTRIES SEE 20-1076. [655983] [MMA] [Entered: 12/12/2019 11:48 AM] (0) |
| Dec 12, 2019 | 4 | ORDER granting Serenity's motion to dismiss [651889-2]. Appeal No. 2020-1076 is dismissed. The revised official caption and short caption for the remaining appeal, Appeal No. 2020-1098, are reflected in this order. Each side shall bear its own costs in Appeal No. 2020-1076. Ferring B.V., Ferring International Center SA, and Ferring Pharmaceuticals, Inc.'s opening brief in Appeal No. 2020-1098 is due within 60 days of the date of filing of this order. ISSUED AS A MANDATE (as to 2020-1076 only): December 12, 2019. Service as of this date by the Clerk of Court. [655970] [20-1076, 20-1098] [LMS] [Entered: 12/12/2019 11:24 AM] (3) |
| Nov 1, 2019 | 3 | Note to file: The following cases are associated: 20-1076 (Lead) with 20-1098 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [646492] [20-1076, 20-1098] [MMA] [Entered: 11/01/2019 04:51 PM] (0) |
| Nov 1, 2019 | 2 | ORDER filed. Appeals 20-1076 and 20-1098 are hereby consolidated. The briefing schedule is set forth in the order. The revised official caption is reflected in the order. Service as of this date by the Clerk of Court. [646490] [20-1076, 20-1098] [MMA] [Entered: 11/01/2019 04:47 PM] (2) |
| Oct 30, 2019 | 1 | Appeal docketed. Received: 10/29/2019. [645719]Entry of Appearance due 11/13/2019. Certificate of Interest is due on 11/13/2019. Docketing Statement due 11/13/2019. Appellants' brief is due 12/30/2019. [MMA] [Entered: 10/30/2019 09:24 AM] (85) |
